Review of Prognostic Significance of Quantitative BPE Measurements
Open Access
- 6 February 2026
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 16 (3) , 495
Abstract
Background/Objectives: Background parenchymal enhancement (BPE) on breast magnetic resonance imaging reflects hormonal and vascular activity of fibroglandular tissue and is studied as a prognostic marker for breast cancer. This paper serves as a review that evaluates quantitative methods for BPE measurements for predicting treatment outcomes. Methods: PubMed was searched for papers on evaluating BPE with outcomes to compare, such as pathologic complete response, recurrence-free survival, disease-free survival, and overall survival, from 2015 to 2025. In total, eleven papers using quantitative methods to measure BPE were selected. Results: Quantitative results showed that BPE reduction during neoadjuvant chemotherapy and high pre-treatment/baseline BPE are linked to improved treatment response and reduced risk of recurrence. Conclusions: Quantitative assessment methods yield objective and reproducible prognostic information. Incorporating quantitative BPE measurements alongside tumor-focused imaging features may further improve predictive accuracy in clinical settings.Keywords
This publication has 29 references indexed in Scilit:
- A deep learning framework to stratify Nottingham histologic grade 2 breast tumors based on dynamic contrast-enhanced MRIEuropean Radiology, 2025
- Are background breast parenchymal features on preoperative breast MRI associated with disease-free survival in patients with invasive breast cancer?La radiologia medica, 2024
- Association between contralateral background parenchymal enhancement on MRI and outcome in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapyDiagnostic and Interventional Imaging, 2022
- Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapyDiagnostic and Interventional Imaging, 2020
- Triple-negative breast cancer: Pretreatment magnetic resonance imaging features and clinicopathological factors associated with recurrenceMagnetic Resonance Imaging, 2020
- Background parenchymal enhancement on breast MRI: A comprehensive reviewJournal of Magnetic Resonance Imaging, 2019
- Role of dynamic contrast‐enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER‐positive, HER2‐negative, node‐negative invasive breast cancerJournal of Magnetic Resonance Imaging, 2018
- Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patientsEuropean Radiology, 2018
- Using deep learning to segment breast and fibroglandular tissue in MRI volumesMedical Physics, 2017
- Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyTranslational Oncology, 2015